Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2555-2557

  Lewinsohn, David M ^a,b,d   Bowden, Raleigh A ^a,c   Mattson, Debra ^a,c   Crawford, Stephen W ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOLYSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SURVIVAL; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0029970801     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2555     Document Type: Article

References (16)

1. Barry, M., M. Russi, L. Armstrong, D. Geller, R. Tesh, L. Dembry, J. P. Gonzalez, A. S. Khan, and C. J. Peters. 1995 Brief report: treatment of a laboratory-acquired Sabi'a virus infection. N. Engl. J. Med. 333:294-296.
2. Canonico, P. G., M. D. Kastello, C. T. Spears, J. R. Brown, E. A. Jackson, and D. E. Jenkins. 1984. Effects of ribavirin on red blood cells. Toxicol. Appl. Pharmacol. 74:155-162.
3. Englund, J. A., C. J. Sullivan, M. C. Jordan, L. P. Dehner, G. M. Vercellotti, and H. H. Balfour. 1988. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 109:203-208.
4. Enria, D. A., and J. I. Maiztegui. 1994. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23:23-31.
5. Hall, C. B., J. T. McBride, E. E. Walsh, D. M. Bell, C. L. Gala, S. Hildreth, L. G. Ten Eyck, and W. Hall. 1983. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N. Engl. J. Med. 308:1443-1447.
6. Harrington, R. D., T. M. Hooton, R. C. Hackman, G. A. Storch, B. Osborne, C. A. Gleaves, A. Benson, and J. D. Meyers. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 165:987-993.
7. Hertz, M. I., J. A. Englund, D. Snover, P. B. Bitterman, and P. B. McGlave. 1989. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 68:269-281.
8. Hruska, J. F., J. M. Bernstein, R. G. Douglas, Jr., and C. B. Hall. 1980. Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob. Agents Chemother. 17:770-775.
9. Huggins, J. W., C. M. Hsiang, T. M. Cosgriff, M. Y. Guang, J. I. Smith, Z. O. Wu, J. W. LeDuc, Z. M. Zheng, J. M. Meegan, Q. N. Wang, et al. 1991. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 164:1119-1127.
10. Kang, J. O., and C. H. Pai. 1989. In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus. Am. J. Clin. Pathol 91: 323-326.
11. Kawana, F., S. Shigeta, and E. De Clercq. 1985. Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro. Antiviral Res. 1:83-88.
12. Liles, W. C, H. Cushing, S. Holt, C. Bryan, and R. C. Hackman. 1993. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant. 2:409-412.
13. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. B. Williams. 1986. Lassa fever: effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
14. Rodriguez, W. J., R. H. Bui, J. D. Connor, H. W. Kim, C. D. Brandt, R. H. Parrott, B. Burch, and J. Mace, 1987. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob. Agents Chemother. 31:1143-1146.
15. Whimbey, E., R. E. Champlin, R. B. Couch, J. A. Englund, J. M. Goodrich, I. Raad, D. Prepiorka, V. A. Lewis, N. Mirza, H. Yousuf, J. J. Tarrand, and G. P. Bodey. 1996. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin. Infect. Dis. 22:778-782.
16. Whimbey, E., R. E. Champlin, J. A. Englund, N. Q. Mirza, P. A. Piedra, J. M. Goodrich, D. Przepiorka, M. A. Luna, R. C, Morice, J. L. Neumann, et al. 1995. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 16:393-399.